INSIDER · CIK 2022214
Peterson Katharine
Chief Accounting Officer at Acrivon Therapeutics, Inc. (ACRV)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$203.01Sold on the market
1Companies
Aug 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202616:10 | Aug 18, 2026 | ACRVAcrivon Therapeutics, Inc. | Chief Accounting Officer | S · Sell | $2.01 | −101 | 18,033 | -1% | −$203.01 |